Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

30,207 total articles

Panasonic Plans U.S. Data-Centre Battery Cell Mass Production in FY2028

Panasonic Plans U.S. Data-Centre Battery Cell Mass Production in FY2028

Panasonic Holdings said it will begin mass production of battery cells for data centre energy storage at a Kansas facility in the financial year 2028 (ending March 2029). The company is reallocating roughly 350 billion yen of a previously announced 500 billion yen AI infrastructure investment to its Energy unit, with 150 billion yen directed to its…

Colombian equities close modestly higher as COLCAP gains 0.45%

Colombian equities close modestly higher as COLCAP gains 0.45%

Colombia's benchmark index finished higher on Wednesday, with the COLCAP rising 0.45% as gains in the Industrials, Services and Agriculture sectors supported the market. Select financials and industrial names led advancers, while construction-related and energy-linked stocks weighed on the downside. Commodity contracts and local FX pairs showed mix…

Teradyne Secures $139.9M Firm-Fixed-Price Contract to Supply Diagnostic Test Station Kits to U.S. Air Force

Teradyne Secures $139.9M Firm-Fixed-Price Contract to Supply Diagnostic Test Station Kits to U.S. Air Force

Teradyne Inc. has been awarded a $139,903,994 firm-fixed-price requirements contract by the U.S. Department of War for versatile diagnostic automatic test station kits. The contract covers kits for assembling standardized, commercially available test equipment, components, and software. Work is to be performed at Robins Air Force Base, Georgia, wit…

Humacyte Announces Underwritten Share Sale; Stock Falls After Hours

Humacyte Announces Underwritten Share Sale; Stock Falls After Hours

Humacyte Inc disclosed an underwritten public offering of common stock, prompting a roughly 6% decline in its shares during after-hours trading. The company said all shares will be sold by Humacyte and that underwriters have a 30-day option to buy up to an additional 15% of the offering. Proceeds are earmarked for commercialization of Symvess, regu…